Archive press release 2016

uMotif technology partnership for Parkinson's trial - 16 December 2016

Global Kinetics Corporation and uMotif have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson’s disease.

Please read the full press release here

FDA clearance received for second generation PKG system - 22 September 2016

Global Kinetics Corporation, leader in health technology for people with Parkinson’s, today announced 510(k) marketing clearance for its next generation wrist-worn Parkinson’s KinetiGraph™ (PKG™) System from the US Food and Drug Administration.

Please read the full press release here

Global Kinetics Corporation announces new President and CEO - 30 August 2016

Leading Australian medical technology company Global Kinetics Corporation (GKC) is delighted to announce the appointment of US-based Timothy I. Still as its new President and CEO.

Please read the full press release here

National Parkinson's Foundation collaborate on clinical research project - 23 June 2016

Global Kinetics Corporation, developer of the Personal KinetiGraph™ (PKG™) mobile health technology for the management of patients with Parkinson’s disease and other movement disorders, and the National Parkinson Foundation announced a clinical research collaboration to study the impact of continuous objective measurement of movement in patients with Parkinson’s disease using the PKG™ Movement Recording System.

Please read the full press release here

Parkinson's Institute to provide patients access to PKG - 15 January 2016

The Parkinson’s Institute and Clinical Center announces their partnership with Global Kinetics Corporation (GKC) in a pilot program that will provide Institute patients with access to an innovative mobile health technology. The Personal KinetiGraph™ (PKG™) is a wrist-worn device that offers comprehensive, automated reporting of a Parkinson’s patient’s movements so that neurologists and other physicians can objectively assess symptoms and response to medications.

Please read the full press release here